The Cerivastatin, cataloged under National Stock Number 6505-01-469-5500, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-469-5500 |
| Item Name | Cerivastatin |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| 99-1121 | 5/1 Secondary reference U.S. Government activity |
| BAYCOL | 5/9 Secondary reference Bayer Healthcare Llc Dba Bayer Healthcare-Viterion |
| NDC00026-2885-51 | 3/9 Design control — primary reference Bayer Healthcare Llc Dba Bayer Healthcare-Viterion |
NSN 6505-01-469-5500 is a Cerivastatin, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-469-5500: Special Features: 0.4 MG TABLETS, 90 TABLETS PER BOTTLE; A PRECURSOR OF CHOLESTEROL; END RESULT IS A REDUCTION IN PLASMA CHOLESTEROL CONCENTRATION; Part Name Assigned by Controlling Agency: CERIVASTATIN TABLETS 0.4MG 90S BT. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.